Good publication practice

Committee on Publication Ethics (COPE): guidelines on good publication practice.

Good publication practice for pharmaceutical companies.

Guidelines on Good Publication Practice (GPP) for pharmaceutical companies are presented. The aim of the guidelines is to ensure that clinical trials sponsored by pharmaceutical companies are published in a responsible and ethical manner. The guidelines cover companies' responsibility to an endeavour to publish results of all studies, companies' relations with investigators, measures to prevent...

Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3.

This updated Good Publication Practice (GPP) guideline, known as GPP3, builds on earlier versions and provides recommendations for individuals and organizations that contribute to the publication of research results sponsored or supported by pharmaceutical, medical device, diagnostics, and biotechnology companies. The recommendations are designed to help individuals and organizations maintain e...

Committee on Publication Ethics. The COPE Report 1999. Guidelines on good publication practice.

Why the guidelines were developed COPE was founded in 1997 to address breaches of research and publication ethics. A voluntary body providing a discussion forum and advice for scientific editors, it aims to find practical ways of dealing with the issues, and to develop good practice. We thought it essential to attempt to define best practice in the ethics of scientific publishing. These guideli...

does surge in research papers symbolize good publication practice? ‑ a preliminary report from india

-